Cargando…
A Possible Contribution of Altered Cathepsin B Expression to the Development of Skin Sclerosis and Vasculopathy in Systemic Sclerosis
Cathepsin B (CTSB) is a proteolytic enzyme potentially modulating angiogenic processes and extracellular matrix remodeling. While matrix metalloproteinases are shown to be implicated in tissue fibrosis and vasculopathy associated with systemic sclerosis (SSc), the role of cathepsins in this disease...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285678/ https://www.ncbi.nlm.nih.gov/pubmed/22384200 http://dx.doi.org/10.1371/journal.pone.0032272 |
_version_ | 1782224507447017472 |
---|---|
author | Noda, Shinji Asano, Yoshihide Akamata, Kaname Aozasa, Naohiko Taniguchi, Takashi Takahashi, Takehiro Ichimura, Yohei Toyama, Tetsuo Sumida, Hayakazu Yanaba, Koichi Tada, Yayoi Sugaya, Makoto Kadono, Takafumi Sato, Shinichi |
author_facet | Noda, Shinji Asano, Yoshihide Akamata, Kaname Aozasa, Naohiko Taniguchi, Takashi Takahashi, Takehiro Ichimura, Yohei Toyama, Tetsuo Sumida, Hayakazu Yanaba, Koichi Tada, Yayoi Sugaya, Makoto Kadono, Takafumi Sato, Shinichi |
author_sort | Noda, Shinji |
collection | PubMed |
description | Cathepsin B (CTSB) is a proteolytic enzyme potentially modulating angiogenic processes and extracellular matrix remodeling. While matrix metalloproteinases are shown to be implicated in tissue fibrosis and vasculopathy associated with systemic sclerosis (SSc), the role of cathepsins in this disease has not been well studied. The aim of this study is to evaluate the roles of CTSB in SSc. Serum pro-CTSB levels were determined by enzyme-linked immunosorbent assay in 55 SSc patients and 19 normal controls. Since the deficiency of transcription factor Fli1 in endothelial cells is potentially associated with the development of SSc vasculopathy, cutaneous CTSB expression was evaluated by immunostaining in Fli1(+/−) and wild type mice as well as in SSc and control subjects. The effects of Fli1 gene silencing and transforming growth factor-β (TGF-β) on CTSB expression were determined by real-time PCR in human dermal microvascular endothelial cells (HDMECs) and dermal fibroblasts, respectively. Serum pro-CTSB levels were significantly higher in limited cutaneous SSc (lcSSc) and late-stage diffuse cutaneous SSc (dcSSc) patients than in healthy controls. In dcSSc, patients with increased serum pro-CTSB levels showed a significantly higher frequency of digital ulcers than those with normal levels. CTSB expression in dermal blood vessels was increased in Fli1(+/−) mice compared with wild type mice and in SSc patients compared with healthy controls. Consistently, Fli1 gene silencing increased CTSB expression in HDMECs. In cultured dermal fibroblasts from early dcSSc, CTSB expression was decreased compared with normal fibroblasts and significantly reversed by TGF-β1 antisense oligonucleotide. In conclusion, up-regulation of endothelial CTSB due to Fli1 deficiency may contribute to the development of SSc vasculopathy, especially digital ulcers, while reduced expression of CTSB in lesional dermal fibroblasts is likely to be associated with skin sclerosis in early dcSSc. |
format | Online Article Text |
id | pubmed-3285678 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-32856782012-03-01 A Possible Contribution of Altered Cathepsin B Expression to the Development of Skin Sclerosis and Vasculopathy in Systemic Sclerosis Noda, Shinji Asano, Yoshihide Akamata, Kaname Aozasa, Naohiko Taniguchi, Takashi Takahashi, Takehiro Ichimura, Yohei Toyama, Tetsuo Sumida, Hayakazu Yanaba, Koichi Tada, Yayoi Sugaya, Makoto Kadono, Takafumi Sato, Shinichi PLoS One Research Article Cathepsin B (CTSB) is a proteolytic enzyme potentially modulating angiogenic processes and extracellular matrix remodeling. While matrix metalloproteinases are shown to be implicated in tissue fibrosis and vasculopathy associated with systemic sclerosis (SSc), the role of cathepsins in this disease has not been well studied. The aim of this study is to evaluate the roles of CTSB in SSc. Serum pro-CTSB levels were determined by enzyme-linked immunosorbent assay in 55 SSc patients and 19 normal controls. Since the deficiency of transcription factor Fli1 in endothelial cells is potentially associated with the development of SSc vasculopathy, cutaneous CTSB expression was evaluated by immunostaining in Fli1(+/−) and wild type mice as well as in SSc and control subjects. The effects of Fli1 gene silencing and transforming growth factor-β (TGF-β) on CTSB expression were determined by real-time PCR in human dermal microvascular endothelial cells (HDMECs) and dermal fibroblasts, respectively. Serum pro-CTSB levels were significantly higher in limited cutaneous SSc (lcSSc) and late-stage diffuse cutaneous SSc (dcSSc) patients than in healthy controls. In dcSSc, patients with increased serum pro-CTSB levels showed a significantly higher frequency of digital ulcers than those with normal levels. CTSB expression in dermal blood vessels was increased in Fli1(+/−) mice compared with wild type mice and in SSc patients compared with healthy controls. Consistently, Fli1 gene silencing increased CTSB expression in HDMECs. In cultured dermal fibroblasts from early dcSSc, CTSB expression was decreased compared with normal fibroblasts and significantly reversed by TGF-β1 antisense oligonucleotide. In conclusion, up-regulation of endothelial CTSB due to Fli1 deficiency may contribute to the development of SSc vasculopathy, especially digital ulcers, while reduced expression of CTSB in lesional dermal fibroblasts is likely to be associated with skin sclerosis in early dcSSc. Public Library of Science 2012-02-23 /pmc/articles/PMC3285678/ /pubmed/22384200 http://dx.doi.org/10.1371/journal.pone.0032272 Text en Noda et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Noda, Shinji Asano, Yoshihide Akamata, Kaname Aozasa, Naohiko Taniguchi, Takashi Takahashi, Takehiro Ichimura, Yohei Toyama, Tetsuo Sumida, Hayakazu Yanaba, Koichi Tada, Yayoi Sugaya, Makoto Kadono, Takafumi Sato, Shinichi A Possible Contribution of Altered Cathepsin B Expression to the Development of Skin Sclerosis and Vasculopathy in Systemic Sclerosis |
title | A Possible Contribution of Altered Cathepsin B Expression to the Development of Skin Sclerosis and Vasculopathy in Systemic Sclerosis |
title_full | A Possible Contribution of Altered Cathepsin B Expression to the Development of Skin Sclerosis and Vasculopathy in Systemic Sclerosis |
title_fullStr | A Possible Contribution of Altered Cathepsin B Expression to the Development of Skin Sclerosis and Vasculopathy in Systemic Sclerosis |
title_full_unstemmed | A Possible Contribution of Altered Cathepsin B Expression to the Development of Skin Sclerosis and Vasculopathy in Systemic Sclerosis |
title_short | A Possible Contribution of Altered Cathepsin B Expression to the Development of Skin Sclerosis and Vasculopathy in Systemic Sclerosis |
title_sort | possible contribution of altered cathepsin b expression to the development of skin sclerosis and vasculopathy in systemic sclerosis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285678/ https://www.ncbi.nlm.nih.gov/pubmed/22384200 http://dx.doi.org/10.1371/journal.pone.0032272 |
work_keys_str_mv | AT nodashinji apossiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis AT asanoyoshihide apossiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis AT akamatakaname apossiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis AT aozasanaohiko apossiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis AT taniguchitakashi apossiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis AT takahashitakehiro apossiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis AT ichimurayohei apossiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis AT toyamatetsuo apossiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis AT sumidahayakazu apossiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis AT yanabakoichi apossiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis AT tadayayoi apossiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis AT sugayamakoto apossiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis AT kadonotakafumi apossiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis AT satoshinichi apossiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis AT nodashinji possiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis AT asanoyoshihide possiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis AT akamatakaname possiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis AT aozasanaohiko possiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis AT taniguchitakashi possiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis AT takahashitakehiro possiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis AT ichimurayohei possiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis AT toyamatetsuo possiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis AT sumidahayakazu possiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis AT yanabakoichi possiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis AT tadayayoi possiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis AT sugayamakoto possiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis AT kadonotakafumi possiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis AT satoshinichi possiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis |